Conrad Wong is currently the Executive Director of Global Regulatory Affairs at Eli Lilly and Company, a position held since 2023, after serving as Senior Director in 2022. With extensive expertise in early phase clinical development of neuroscience medications and a strong background in regulatory strategies and agency interactions, Conrad has significantly contributed to the field of medication development for various disorders. Prior to their role at Eli Lilly, Conrad held positions as an Assistant Professor at both Johns Hopkins University School of Medicine and the University of Kentucky College of Medicine, focusing on human behavioral pharmacology and drug addiction research. Conrad earned a Ph.D. in Experimental Psychology from the University of Vermont in 2000.
This person is not in the org chart
This person is not in any teams
This person is not in any offices